Oxford, UK. Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has co-ordinated a secondary placing of shares on behalf of certain shareholders. The majority of this transaction was the acquisition of Illumina’s 13.5% shareholding in Oxford Nanopore by other investors for £56.4 million. Oxford Nanopore announced in October […]
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the release of SeqCap EZ Exome Designs for target enrichment of the wheat, barley and maize genomes. These agriculture exome designs were developed with key opinion leaders in crop genome research. The goal is to provide researchers a cost-effective and easy-to-use alternative sequencing method beyond whole genome sequencing. […]
Redwood City, California –– GenapSys™, Inc. (GenapSys), a provider of Next Generation Sequencing (NGS) systems, today announced it has raised $37M to commercialize the GENIUS™ 110 system (Gene Electronic Nano-Integrated Ultra-Sensitive), a fully integrated DNA Sequencing system for the rapidly evolving NGS market. The Series B financing includes new investors Yuri Milner, Stanford StartX Fund, […]
PHOENIX, Arizona; REDWOOD CITY, California; and HILDEN, Germany — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced it has begun enrolling molecular diagnostics laboratories in an Early Access Program to complete the development of a new web-based solution to deliver faster, easier-to-use and high-confidence clinical interpretation and reporting of observed gene variants in […]
PHOENIX — Maverix Biomics Inc., today announced at the Association of Molecular Pathology (AMP) 2013 Annual Meeting in Phoenix, Arizona that the company has signed a non-exclusive strategic co-marketing agreement with QIAGEN to streamline the interpretation of raw next-generation sequencing (NGS) data into meaningful and actionable insights. The Maverix Analytic Platform will complement QIAGEN’s sample-to-insight […]
CARLSBAD, Calif. and UTRECHT, The Netherlands –– One of the most comprehensive studies of genetic mutations in ovarian cancer was published today, demonstrating an unprecedented level of genetic variation that exists in both primary tumors and metastatic lesions of ovarian cancer. The study highlights potential new pathways for therapeutic intervention and suggests that sampling and […]
SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced it has appointed Francis deSouza to the role of President. Mr. deSouza will report to Chief Executive Officer Jay Flatley and will lead Illumina’s business units and the core functions responsible for envisioning, developing and producing the company’s products. He will also become part of Illumina’s executive […]
Salt Lake City, UT — Tute Genomics made their public debut last week at the 2013 American Society for Human Genetics (ASHG) conference in Boston, MA. Tute, founded in 2012, is a cloud-based, professional grade clinical genome interpretation engine that has the ability to analyze and annotate entire human genomes in a rapid and cost-effective […]
CONSHOHOCKEN, PA — Instem, a leading provider of IT solutions to the global early development healthcare market, announced today it has introduced additional enhancements to the recently released version 8.4 of its Sequence Retrieval System, also known as “SRS”. SRS is a proven and scalable data integration platform that is used at both commercial and […]
GLASGOW, Scotland — Life Technologies Corporation (NASDAQ: LIFE) today announces four new members in Europe to its Ion AmpliSeq™ Exome Certified Service Provider program, an organization of some of the world’s top service providers that sequence and analyze human exomes. Using the Ion AmpliSeq™ Exome Kit, the Ion Proton™ Sequencer, and the Ion Reporter™ Software, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
